Inflammatory Changes Seen in Irritable Bowel Chronic Pelvic PainA DGReview of :"Neurogenic inflammation and chronic pelvic pain"World Journal of Urology
http://www.docguide.com/news/content.nsf/n...ritable%2CbowelLecture: Neurophysiology of Brain-Gut Interactions During Stress Presenter: Jack Wood, PhD "Jack Wood, PhDProfessor of Physiology and Internal MedicineChairman Emeritus, Department of PhysiologyThe Ohio State University College of Medicine Dr. Wood was the first to use microelectrodes to record the electrical and synaptic behavior of neurons in the enteric nervous system. He coined the term "brain-in-the-gut" in view of emerging evidence that the enteric nervous system had neurophysiological properties like the brain and spinal cord. In recent years he has focused on signaling interactions between the enteric immune system and the brain-in-the-gut during infectious enteritis and food allergy. In this lecture he shows how the central nervous system, enteric nervous system and intestinal immune system are integrated during physical and emotional stress to produce irritable bowel symptoms of diarrhea and abdominal pain and discomfort. "
http://www.conference-cast.com/ibs/Lecture...cfm?LectureID=7"Irritable bowel syndrome (IBS) is a functional intestinal disorder characterised by changes in bowel habits, which range from constipation to diarrhoea, associated with abdominal discomfort or overt pain (Drossman et al., 2002; Talley & Spiller, 2002). These symptoms can be attributed to modifications of the sensory-motor function of the intestine, where the substrate(s) involved could reside within the intestinal wall, in extrinsic ganglia, or in the central nervous system (Camilleri, 2001). As has recently been pointed out (Drossman et al., 2003), psychological distress, affective disorders, and narcotic abuse have to be considered as important ethiopathogenetic factors for IBS; however, there is little doubt that such factors also trigger peripheral changes. In accordance with this concept, stress can reactivate a previous peripheral inflammation (Collins, 2001), thus establishing a link between psychological factors and post-infectious (or post-dysenteric) IBS (Spiller et al., 2000). Current pharmacological treatments are aimed at controlling specific symptoms (e.g., tricyclic antidepressants for pain, 5-HT3 antagonists or spasmolytics for diarrhoea, 5-HT4 agonists for constipation) and the improvement obtained is relatively modest (Mertz, 2003). Therefore, a single drug that could potentially affect all of these symptoms would represent an important therapeutic achievement (Kirkup et al., 2001)."
http://www.nature.com/bjp/journal/v141/n8/full/0705751a.html